Sign in to continue:

Saturday, February 21st, 2026

Sitra Holdings (International) Ltd FY2025 Results: Revenue Up 21%, No Dividend Declared for 2025

Sitra Holdings (International) Ltd – FY2025 Financial Review

Sitra Holdings (International) Ltd, a Singapore-listed company engaged in the import/export and distribution of wood-based products and property development, has released its unaudited financial results for the year ended 31 December 2025. Below, we analyze key financial metrics, trends, and material developments disclosed in the report.

Key Financial Metrics & Performance Table

Metric 2H2025 1H2025 2H2024 YoY Change (2H) QoQ Change (2H vs 1H)
Revenue (S\$) 7,706,298 7,670,282 5,948,828 +30% +0.5%
Gross Profit (S\$) 454,092 677,900 607,359 -25% -33%
Net Loss (S\$) (700,072) (598,669) (345,980) +103% +17%
EPS (Loss per share, S\$ cents) (0.04) (0.04) (0.02) -100% 0%
Dividend per Share (S\$) 0.00 0.00 0.00 No Change No Change

Historical Performance Trends

  • Revenue Growth: FY2025 revenue rose 21% YoY to S\$15.38 million, driven by higher demand in Australia/New Zealand (+10%) and Europe (+30%).
  • Profitability: Despite revenue growth, FY2025 net loss widened to S\$1.30 million (+11% YoY), and gross profit declined 5% YoY. Gross margins continued to contract (7.36% in FY2025 vs. 9.39% in FY2024), reflecting severe raw material cost pressures.
  • Cash Position: Cash and bank balances improved to S\$0.33 million (up from S\$0.24 million at end-FY2024), primarily due to a director advance, not from operating profit.
  • Net Asset Value: Net asset value per share fell to S\$0.43 (from S\$0.52), reflecting accumulated losses and negative comprehensive income.

Exceptional Items and Notable Developments

  • Other Gains/Losses: FY2025 saw a swing from net gains of S\$346,872 in FY2024 to net losses of S\$67,372, mainly due to the absence of a prior-year gain on remeasurement of a financial liability.
  • Expense Controls: Administrative and selling expenses fell YoY, reflecting some cost discipline, but these improvements were not enough to offset margin pressures.
  • Asset Revaluation: The company booked a revaluation gain of S\$560,351 on property, plant, and equipment, lower than the S\$682,638 gain in the previous year.
  • No Dividend: No dividend was declared due to continuing accumulated losses.
  • Related-party Transactions: There were no material related-party transactions or significant asset sales, placements, or share buybacks in the period.

Chairman’s Statement

“The competitive landscape in our primary markets of Europe, Australia, and New Zealand remains uncertain. Geopolitical tensions, an increase in material prices due to tight supply, and weak demand have impacted our margin across all market segments.

We anticipate that these headwinds will persist. Ongoing uncertainties and increasing prices of materials are expected to continue to influence the purchasing decisions of our customers and our operations. We will continue to navigate these challenges, exploring opportunities to diversify our revenue streams and optimizing our operations to ensure long-term sustainability.”

The tone is notably cautious and somewhat negative, with management highlighting persistent cost pressures, weak demand, and no near-term resolution to margin compression.

Balance Sheet & Cash Flow Review

  • Assets: Total assets decreased to S\$11.26 million, mainly due to lower inventories and currency translation losses.
  • Liabilities: Total liabilities increased to S\$4.38 million, with new advances from directors and revaluation of financial liabilities.
  • Cash Flows: Operating cash flow was negative (S\$122,503 used), with the deficit covered by a S\$381,000 director advance. Capital expenditures were minimal.

Dividends

  • No dividend was proposed for FY2025, same as FY2024.
  • The company explicitly states it cannot pay dividends due to accumulated losses.

Events & Risks Impacting Outlook

  • Macroeconomic Headwinds: Management expects ongoing margin and demand pressure due to geopolitical and supply chain issues.
  • No New Business Segments: Property development in Bintan remains inactive; no revenue was recorded from this business.
  • No Major Legal, Regulatory, or Tax Changes: None disclosed.
  • No Share Buybacks or Dilution: Capital structure is unchanged.

Conclusion and Investment Recommendations

Overall Assessment: Sitra Holdings’ financial performance in FY2025 remains weak, despite respectable revenue growth. Persistent and rising losses, ongoing margin compression from high material costs, negative operating cash flow, and a downbeat outlook from management all point to significant challenges ahead. The company’s inability to pay dividends and lack of clear catalysts for margin recovery further dampen the investment case.

  • If you currently hold Sitra Holdings shares: Consider reducing or exiting your position, particularly if you require capital preservation or dividends. The company’s outlook remains challenging, and recovery prospects appear limited without an improvement in cost structure or a new growth engine.
  • If you do not currently hold Sitra Holdings shares: There is little reason to initiate a position. Wait for evidence of a sustainable turnaround, especially a return to profitability, margin recovery, or successful execution of new business initiatives.

Disclaimer: This analysis is based solely on information disclosed in the company’s FY2025 report. It does not constitute investment advice. Please consult your own financial advisor before making any investment decisions.

View Sitra Historical chart here



FY24 Financial Analysis of UG Healthcare Corporation: Profitability Challenges Amid Industry Contraction and Debt Pressures

Business Description: UG Healthcare Corporation (UGHC) is a global manufacturer and distributor of natural and synthetic gloves. The company operates through two business segments: the manufacturing segment, which is primarily focused on producing gloves,...

GuocoLand Limited 1H FY26 Results: 14% Profit Growth, No Interim Dividend Declared for Half Year Ended 31 Dec 2025

GuocoLand Limited 1H FY2026 Financial Results: Analysis & Investor Insights GuocoLand Limited, a major property developer and investor in Singapore, Malaysia, and China, has released its unaudited condensed interim financial statements for the half-year...

China Medical System Holdings Limited Interim Results H1 2025: Turnover Up 10.8%, Profit Rises 3.1%, Declares Interim Dividend of RMB0.1555 Per Share 144

China Medical System Holdings Limited (CMS) Interim Results Analysis: H1 2025 China Medical System Holdings Limited (CMS), a Cayman Islands-incorporated pharmaceutical group, released its unaudited interim results for the six months ended 30 June...

   Ad